Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 2000, p. 1930-1935, Vol. 44, No. 7
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Prevalence of
-Lactamases among 1,072 Clinical
Strains of Proteus mirabilis: a 2-Year Survey in a
French Hospital
C.
Chanal,1,*
R.
Bonnet,1
C.
De
Champs,1
D.
Sirot,1
R.
Labia,2 and
J.
Sirot1
Laboratoire de Bactériologie,
Faculté de Médecine, 63001 Clermont-Ferrand
Cedex,1 and UMR 175, CNRS-MNHN,
29000 Quimper,2 France
Received 27 September 1999/Returned for modification 22 February
2000/Accepted 12 April 2000
-Lactam resistance was studied in 1,072 consecutive P. mirabilis clinical strains isolated at the Clermont-Ferrand
teaching hospital between April 1996 and March 1998. The frequency of
amoxicillin resistance was 48.5%. Among the 520 amoxicillin-resistant
isolates, three resistance phenotypes were detected: penicillinase (407 strains [78.3%]), extended-spectrum
-lactamase (74 strains
[14.2%]), and inhibitor resistance (39 strains [7.5%]). The
penicillinase phenotype isolates were divided into three groups
according to the level of resistance to
-lactams, which was shown to
be related to the strength of the promoter. The characterization of the
different
-lactamases showed that amoxicillin resistance in P. mirabilis was almost always (97%) associated with TEM or
TEM-derived
-lactamases, most of which evolved via TEM-2.
*
Corresponding author. Mailing address: Laboratoire de
Bactériologie, Faculté de Médecine, 28, Place Henri
Dunant, 63001 Clermont-Ferrand Cedex, France. Phone: 33 (0)4 73 60 80 18. Fax: 33 (0)4 73 27 74 94. E. mail:
Catherine.CHANAL{at}u-clermont1.fr.
Antimicrobial Agents and Chemotherapy, July 2000, p. 1930-1935, Vol. 44, No. 7
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Savini, V., Catavitello, C., Talia, M., Di Berardino, F., Manna, A., Balbinot, A., Febbo, F., Carlino, D., Fioritoni, F., Di Bonaventura, G., D'Antonio, D.
(2008). Ulcer Infection by ES{beta}L-Producing Proteus mirabilis: A Case Report. INT J LOW EXTREM WOUNDS
7: 99-101
[Abstract]
-
Aragon, L. M., Mirelis, B., Miro, E., Mata, C., Gomez, L., Rivera, A., Coll, P., Navarro, F.
(2008). Increase in {beta}-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type {beta}-lactamases. J Antimicrob Chemother
61: 1029-1032
[Abstract]
[Full Text]
-
Park, Y.-J., Lee, S., Kim, Y. R., Oh, E.-J., Woo, G.-J., Lee, K.
(2006). Occurrence of extended-spectrum {beta}-lactamases and plasmid-mediated AmpC {beta}-lactamases among Korean isolates of Proteus mirabilis. J Antimicrob Chemother
57: 156-158
[Full Text]
-
Literacka, E., Empel, J., Baraniak, A., Sadowy, E., Hryniewicz, W., Gniadkowski, M.
(2004). Four Variants of the Citrobacter freundii AmpC-Type Cephalosporinases, Including Novel Enzymes CMY-14 and CMY-15, in a Proteus mirabilis Clone Widespread in Poland. Antimicrob. Agents Chemother.
48: 4136-4143
[Abstract]
[Full Text]
-
Nagano, N., Shibata, N., Saitou, Y., Nagano, Y., Arakawa, Y.
(2003). Nosocomial Outbreak of Infections by Proteus mirabilis That Produces Extended-Spectrum CTX-M-2 Type {beta}-Lactamase. J. Clin. Microbiol.
41: 5530-5536
[Abstract]
[Full Text]
-
Barlow, M., Hall, B. G.
(2003). Experimental Prediction of the Natural Evolution of Antibiotic Resistance. Genetics
163: 1237-1241
[Abstract]
[Full Text]
-
Naas, T., Zerbib, M., Girlich, D., Nordmann, P.
(2003). Integration of a Transposon Tn1-Encoded Inhibitor-Resistant {beta}-Lactamase Gene, blaTEM-67 from Proteus mirabilis, into the Escherichia coli Chromosome. Antimicrob. Agents Chemother.
47: 19-26
[Abstract]
[Full Text]
-
Mutnick, A. H, Kirby, J. T, Jones, R. N
(2003). CANCER Resistance Surveillance Program: Initial Results from Hematology-Oncology Centers in North America. The Annals of Pharmacotherapy
37: 47-56
[Abstract]
[Full Text]
-
Miro, E., Navarro, F., Mirelis, B., Sabate, M., Rivera, A., Coll, P., Prats, G.
(2002). Prevalence of Clinical Isolates of Escherichia coli Producing Inhibitor-Resistant {beta}-Lactamases at a University Hospital in Barcelona, Spain, over a 3-Year Period. Antimicrob. Agents Chemother.
46: 3991-3994
[Abstract]
[Full Text]
-
Bonnet, R., Marchandin, H., Chanal, C., Sirot, D., Labia, R., De Champs, C., Jumas-Bilak, E., Sirot, J.
(2002). Chromosome-Encoded Class D {beta}-Lactamase OXA-23 in Proteus mirabilis. Antimicrob. Agents Chemother.
46: 2004-2006
[Abstract]
[Full Text]
-
Pagani, L., Migliavacca, R., Pallecchi, L., Matti, C., Giacobone, E., Amicosante, G., Romero, E., Rossolini, G. M.
(2002). Emerging Extended-Spectrum {beta}-Lactamases in Proteus mirabilis. J. Clin. Microbiol.
40: 1549-1552
[Abstract]
[Full Text]
-
Barlow, M., Hall, B. G.
(2002). Predicting Evolutionary Potential: In Vitro Evolution Accurately Reproduces Natural Evolution of the TEM {beta}-Lactamase. Genetics
160: 823-832
[Abstract]
[Full Text]